Antigen‐specific antibody responses in lupus patients following immunization

DF Battafarano, NJ Battafarano… - … : Official Journal of …, 1998 - Wiley Online Library
Objective To determine the safety and efficacy of 3 clinically relevant vaccines in patients
with systemic lupus erythematosus (SLE). Methods We studied 73 consecutive SLE patients …

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload.

…, AL Fracanzani, L Binelli, N Battafarano… - The Journal of …, 1997 - europepmc.org
Objective To evaluate the frequency of arthropathy and osteoporosis in genetic
hemochromatosis (GH) and to quantify potential risk factors for these 2 conditions. Methods …

[HTML][HTML] Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

…, F Masedu, S Alvaro, P Airò, N Battafarano… - PLoS …, 2019 - journals.plos.org
Background The inflammatory contribution to type 2 diabetes (T2D) has suggested new
therapeutic targets using biologic drugs designed for rheumatoid arthritis (RA). On this basis, we …

Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with …

A Marchesoni, N Battafarano, M Arreghini… - …, 2003 - academic.oup.com
Objective. To determine whether patients with early rheumatoid arthritis (RA) treated with
cyclosporin A (CsA) and methotrexate (MTX) in combination for 12 months show a lower rate of …

Cyclosporin A in the treatment of adult onset Still's disease.

A Marchesoni, GP Ceravolo, N Battafarano… - The Journal of …, 1997 - europepmc.org
Objective To determine whether cyclosporin A (CyA) is a useful option in the treatment of
adult onset Still's disease (ASD). Methods Low dose CyA was given to 6 patients with chronic …

Iron metabolism in thalassemia intermedia.

G Fiorelli, S Fargion, A Piperno, N Battafarano… - …, 1990 - europepmc.org
Iron overload is frequently present in patients with thalassemia intermedia, and it becomes
evident mainly after the second and third decades of life. The degree of the iron load is …

Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients

G De Marco, A Cattaneo, N Battafarano… - Archives of …, 2012 - Springer
… Enrolled patients (n = 277) are depicted in black, the remaining psoriatic subjects followed
up in the clinic (n = 933) are depicted in grey. Topical therapies are corticosteroids or vitamin …

Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab

…, M Arreghini, B Panni, N Battafarano… - …, 2003 - academic.oup.com
S ir, As a result of the introduction of new disease‐modifying anti‐rheumatic drugs (DMARDs)
for the treatment of rheumatoid arthritis (RA), patients with refractory RA tend to be treated …

[PDF][PDF] Ultrasound assessment of lacrimal glands: A cross-sectional study in healthy subjects and a preliminary study in primary Sjögren's syndrome patients

…, MV De Souza, N Battafarano, N Del Papa… - Clin Exp …, 2020 - clinexprheumatol.org
Objective. This study aimed to: i) perform an ultrasonographic (US) evaluation of the lacrimal
glands (LGs) in healthy subjects in order to define the sonographic elementary lesions …

Long-term survival of methotrexate in psoriatic arthritis

…, F Desiati, D Mazzocchi, L Rotunno, N Battafarano… - Reumatismo, 2009 - reumatismo.org
Objective. The purpose of this study was to evaluate the long-term survival rate of
Methotrexate (MTX) in the peripheral joint involvement of psoriatic arthritis (PsA) in a setting of …